{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:28:30Z","timestamp":1794202110280,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8082","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,9,25]]},"DOI":"10.1038\/s41586-025-09330-2","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:04:02Z","timestamp":1753887842000},"page":"1020-1028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life"],"prefix":"10.1038","volume":"645","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4330-4659","authenticated-orcid":false,"given":"Amir","family":"Ardeshir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"O\u2019Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-0787","authenticated-orcid":false,"given":"Isha","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-5878","authenticated-orcid":false,"given":"Siddhartha","family":"Shandilya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3874-3585","authenticated-orcid":false,"given":"Lincoln L. J.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo J.","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4338-4660","authenticated-orcid":false,"given":"Patricia A.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas A. B.","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian P.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0560-5407","authenticated-orcid":false,"given":"Jose M.","family":"Martinez-Navio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-7597","authenticated-orcid":false,"given":"Matthew R.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7375-1337","authenticated-orcid":false,"given":"Koen K. A.","family":"Van Rompay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1773-2406","authenticated-orcid":false,"given":"Diogo M.","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Lifson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-9012","authenticated-orcid":false,"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2990-5319","authenticated-orcid":false,"given":"Michael","family":"Farzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5747-064X","authenticated-orcid":false,"given":"Jishnu","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8336-216X","authenticated-orcid":false,"given":"Mauricio A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"9330_CR1","unstructured":"UNAIDS. The Urgency of Now: AIDS at a Crossroads. 2024 Global AIDS Update (Joint United Nations Programme on HIV\/AIDS, 2024)."},{"key":"9330_CR2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","volume":"384","author":"L Corey","year":"2021","unstructured":"Corey, L. et al. Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition. N. Engl. J. Med. 384, 1003\u20131014 (2021).","journal-title":"N. Engl. J. Med."},{"key":"9330_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/172603a0","volume":"172","author":"RE Billingham","year":"1953","unstructured":"Billingham, R. E., Brent, L. & Medawar, P. B. Actively acquired tolerance of foreign cells. Nature 172, 603\u2013606 (1953).","journal-title":"Nature"},{"key":"9330_CR4","first-page":"357","volume":"239","author":"RE Billingham","year":"1956","unstructured":"Billingham, R. E., Brent, L. & Medawar, P. B. Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Phil. Trans. R. Soc. B 239, 357\u2013414 (1956).","journal-title":"Phil. Trans. R. Soc. B"},{"key":"9330_CR5","unstructured":"Women and HIV. A Spotlight on Adolescent Girls and Young Women (UNAIDS, 2019)."},{"key":"9330_CR6","unstructured":"World Health Organization. HIV Drug Resistance Report (2019)."},{"key":"9330_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/17512433.2018.1393331","volume":"11","author":"DF Clarke","year":"2018","unstructured":"Clarke, D. F. et al. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations. Expert Rev. Clin. Pharmacol. 11, 83\u201393 (2018).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"9330_CR8","doi-asserted-by":"publisher","first-page":"S562","DOI":"10.1093\/cid\/ciac754","volume":"75","author":"EJ Abrams","year":"2022","unstructured":"Abrams, E. J., Capparelli, E., Ruel, T. & Mirochnick, M. Potential of long-acting products to transform the treatment and prevention of human immunodeficiency virus (HIV) in infants, children, and adolescents. Clin. Infect. Dis. 75, S562\u2013S570 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"9330_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/COH.0000000000000881","volume":"19","author":"B Cockbain","year":"2024","unstructured":"Cockbain, B., Fidler, S. & Lyall, H. Preventing perinatal HIV acquisition; current gaps and future perspectives. Curr. Opin. HIV AIDS 19, 293\u2013304 (2024).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"9330_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nm.4063","volume":"22","author":"AJ Hessell","year":"2016","unstructured":"Hessell, A. J. et al. Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nat. Med. 22, 362\u2013368 (2016).","journal-title":"Nat. Med."},{"key":"9330_CR11","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nm.2233","volume":"16","author":"CT Ng","year":"2010","unstructured":"Ng, C. T. et al. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat. Med. 16, 1117\u20131119 (2010).","journal-title":"Nat. Med."},{"key":"9330_CR12","doi-asserted-by":"publisher","first-page":"eadh0004","DOI":"10.1126\/scitranslmed.adh0004","volume":"15","author":"RL Shapiro","year":"2023","unstructured":"Shapiro, R. L. et al. Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana. Sci. Transl. Med. 15, eadh0004 (2023).","journal-title":"Sci. Transl. Med."},{"key":"9330_CR13","doi-asserted-by":"publisher","first-page":"100316","DOI":"10.1016\/j.jve.2023.100316","volume":"9","author":"PA Hahn","year":"2023","unstructured":"Hahn, P. A. & Martins, M. A. Adeno-associated virus-vectored delivery of HIV biologics: the promise of a \u201csingle-shot\u201d functional cure for HIV infection. J. Virus Erad. 9, 100316 (2023).","journal-title":"J. Virus Erad."},{"key":"9330_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug. Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"9330_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-020-01182-9","volume":"27","author":"R Sender","year":"2021","unstructured":"Sender, R. & Milo, R. The distribution of cellular turnover in the human body. Nat. Med. 27, 45\u201348 (2021).","journal-title":"Nat. Med."},{"key":"9330_CR16","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.4049\/jimmunol.0901481","volume":"183","author":"TR Kollmann","year":"2009","unstructured":"Kollmann, T. R. et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 183, 7150\u20137160 (2009).","journal-title":"J. Immunol."},{"key":"9330_CR17","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.4049\/jimmunol.177.3.1956","volume":"177","author":"O Levy","year":"2006","unstructured":"Levy, O. et al. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 177, 1956\u20131966 (2006).","journal-title":"J. Immunol."},{"key":"9330_CR18","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1128\/IAI.70.12.6583-6588.2002","volume":"70","author":"JW Upham","year":"2002","unstructured":"Upham, J. W. et al. Development of interleukin-12-producing capacity throughout childhood. Infect. Immun. 70, 6583\u20136588 (2002).","journal-title":"Infect. Immun."},{"key":"9330_CR19","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1126\/science.1164511","volume":"322","author":"JE Mold","year":"2008","unstructured":"Mold, J. E. et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 1562\u20131565 (2008).","journal-title":"Science"},{"key":"9330_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.exphem.2004.03.012","volume":"32","author":"Y Takahata","year":"2004","unstructured":"Takahata, Y. et al. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp. Hematol. 32, 622\u2013629 (2004).","journal-title":"Exp. Hematol."},{"key":"9330_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nm1126","volume":"10","author":"X Fan","year":"2004","unstructured":"Fan, X. et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat. Med. 10, 1227\u20131233 (2004).","journal-title":"Nat. Med."},{"key":"9330_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature14264","volume":"519","author":"MR Gardner","year":"2015","unstructured":"Gardner, M. R. et al. AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges. Nature 519, 87\u201391 (2015).","journal-title":"Nature"},{"key":"9330_CR23","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.1207227","volume":"333","author":"JF Scheid","year":"2011","unstructured":"Scheid, J. F. et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633\u20131637 (2011).","journal-title":"Science"},{"key":"9330_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ymthe.2019.01.004","volume":"27","author":"MR Gardner","year":"2019","unstructured":"Gardner, M. R. et al. Anti-drug antibody responses impair prophylaxis mediated by AAV-delivered HIV-1 broadly neutralizing antibodies. Mol. Ther. 27, 650\u2013660 (2019).","journal-title":"Mol. Ther."},{"key":"9330_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/mt.2015.191","volume":"24","author":"JM Martinez-Navio","year":"2016","unstructured":"Martinez-Navio, J. M. et al. Host anti-antibody responses following adeno-associated virus-mediated delivery of antibodies against HIV and SIV in rhesus monkeys. Mol. Ther. 24, 76\u201386 (2016).","journal-title":"Mol. Ther."},{"key":"9330_CR26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41591-022-01762-x","volume":"28","author":"JP Casazza","year":"2022","unstructured":"Casazza, J. P. et al. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial. Nat. Med. 28, 1022\u20131030 (2022).","journal-title":"Nat. Med."},{"key":"9330_CR27","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1016\/S2352-3018(19)30003-7","volume":"6","author":"FH Priddy","year":"2019","unstructured":"Priddy, F. H. et al. Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial. Lancet HIV 6, e230\u2013e239 (2019).","journal-title":"Lancet HIV"},{"key":"9330_CR28","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jama.283.9.1167","volume":"283","author":"R Nduati","year":"2000","unstructured":"Nduati, R. et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283, 1167\u20131174 (2000).","journal-title":"JAMA"},{"key":"9330_CR29","unstructured":"World Health Organization (eds). Guideline: Updates on HIV and Infant Feeding: The Duration of Breastfeeding, and Support from Health Services to Improve Feeding Practices Among Mothers Living with HIV (WHO & UNICEF, 2016)."},{"key":"9330_CR30","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1097\/QAD.0b013e32835d5226","volume":"27","author":"A Cournil","year":"2013","unstructured":"Cournil, A. et al. Relationship between mortality and feeding modality among children born to HIV-infected mothers in a research setting: the Kesho Bora study. AIDS 27, 1621\u20131630 (2013).","journal-title":"AIDS"},{"key":"9330_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.exger.2016.12.005","volume":"94","author":"JA Mattison","year":"2017","unstructured":"Mattison, J. A. & Vaughan, K. L. An overview of nonhuman primates in aging research. Exp. Gerontol. 94, 41\u201345 (2017).","journal-title":"Exp. Gerontol."},{"key":"9330_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nri.2017.38","volume":"17","author":"JM Kinder","year":"2017","unstructured":"Kinder, J. M., Stelzer, I. A., Arck, P. C. & Way, S. S. Immunological implications of pregnancy-induced microchimerism. Nat. Rev. Immunol. 17, 483\u2013494 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"9330_CR33","unstructured":"Immunization, Vaccines and Biologicals (eds) WHO Preferred Product Characteristics for Monoclonal Antibodies for HIV Prevention (WHO, 2022)."},{"key":"9330_CR34","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1126\/science.271.5256.1723","volume":"271","author":"JP Ridge","year":"1996","unstructured":"Ridge, J. P., Fuchs, E. J. & Matzinger, P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271, 1723\u20131726 (1996).","journal-title":"Science"},{"key":"9330_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/TP.0b013e3182782fc1","volume":"95","author":"J Leventhal","year":"2013","unstructured":"Leventhal, J. et al. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation 95, 169\u2013176 (2013).","journal-title":"Transplantation"},{"key":"9330_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jaci.2015.03.013","volume":"136","author":"B Chaigne","year":"2015","unstructured":"Chaigne, B. & Watier, H. Monoclonal antibodies in excess: a simple way to avoid immunogenicity in patients. J. Allergy Clin. Immunol. 136, 814\u2013816 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"9330_CR37","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","volume":"41","author":"RN Maini","year":"1998","unstructured":"Maini, R. N. et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 41, 1552\u20131563 (1998).","journal-title":"Arthritis Rheum."},{"key":"9330_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coi.2019.07.011","volume":"61","author":"L Steinman","year":"2019","unstructured":"Steinman, L., Ho, P. P., Robinson, W. H., Utz, P. J. & Villoslada, P. Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity. Curr. Opin. Immunol. 61, 46\u201353 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"9330_CR39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1086\/595830","volume":"199","author":"R Calcedo","year":"2009","unstructured":"Calcedo, R., Vandenberghe, L. H., Gao, G., Lin, J. & Wilson, J. M. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J. Infect. Dis. 199, 381\u2013390 (2009).","journal-title":"J. Infect. Dis."},{"key":"9330_CR40","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/CVI.05107-11","volume":"18","author":"R Calcedo","year":"2011","unstructured":"Calcedo, R. et al. Adeno-associated virus antibody profiles in newborns, children, and adolescents. Clin. Vaccine Immunol. 18, 1586\u20131588 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"9330_CR41","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2005-08-3229","volume":"107","author":"CD Scallan","year":"2006","unstructured":"Scallan, C. D. et al. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Blood 107, 1810\u20131817 (2006).","journal-title":"Blood"},{"key":"9330_CR42","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1016\/j.vaccine.2016.10.053","volume":"34","author":"JA Greig","year":"2016","unstructured":"Greig, J. A. et al. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques. Vaccine 34, 6323\u20136329 (2016).","journal-title":"Vaccine"},{"key":"9330_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.omtm.2017.07.003","volume":"6","author":"A Bennett","year":"2017","unstructured":"Bennett, A. et al. Thermal stability as a determinant of AAV serotype identity. Mol. Ther. Methods Clin. Dev. 6, 171\u2013182 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"9330_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0140-6736(23)00860-7","volume":"402","author":"GGBD 2019 Child and Adolescent Communicable Disease Collaborators.","year":"2023","unstructured":"GGBD 2019 Child and Adolescent Communicable Disease Collaborators. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet 402, 313\u2013335 (2023).","journal-title":"Lancet"},{"key":"9330_CR45","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1056\/NEJMe2402430","volume":"390","author":"T Mundel","year":"2024","unstructured":"Mundel, T. The quest for transformative tools to eradicate malaria. N. Engl. J. Med. 390, 1620\u20131621 (2024).","journal-title":"N. Engl. J. Med."},{"key":"9330_CR46","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.1128\/JVI.00649-08","volume":"82","author":"M Penaud-Budloo","year":"2008","unstructured":"Penaud-Budloo, M. et al. Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle. J. Virol. 82, 7875\u20137885 (2008).","journal-title":"J. Virol."},{"key":"9330_CR47","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/mt.2008.87","volume":"16","author":"A Toromanoff","year":"2008","unstructured":"Toromanoff, A. et al. Safety and efficacy of regional intravenous (RI) versus intramuscular (IM) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol. Ther. 16, 1291\u20131299 (2008).","journal-title":"Mol. Ther."},{"key":"9330_CR48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/microorganisms12020384","volume":"12","author":"OW Merten","year":"2024","unstructured":"Merten, O. W. Development of stable packaging and producer cell lines for the production of AAV vectors. Microorganisms 12, 384 (2024).","journal-title":"Microorganisms"},{"key":"9330_CR49","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","volume":"184","author":"M Tabebordbar","year":"2021","unstructured":"Tabebordbar, M. et al. Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell 184, 4919\u20134938.e22 (2021).","journal-title":"Cell"},{"key":"9330_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-024-07800-7","volume":"634","author":"M Kliegman","year":"2024","unstructured":"Kliegman, M. et al. A roadmap for affordable genetic medicines. Nature 634, 307\u2013314 (2024).","journal-title":"Nature"},{"key":"9330_CR51","first-page":"E3413","volume":"113","author":"H Li","year":"2016","unstructured":"Li, H. et al. Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques. Proc. Natl Acad. Sci. USA 113, E3413\u2013E3422 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9330_CR52","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1172\/JCI68205","volume":"123","author":"SM Faust","year":"2013","unstructured":"Faust, S. M. et al. CpG-depleted adeno-associated virus vectors evade immune detection. J. Clin. Invest. 123, 2994\u20133001 (2013).","journal-title":"J. Clin. Invest."},{"key":"9330_CR53","first-page":"14D.1","volume":"14","author":"C Mueller","year":"2012","unstructured":"Mueller, C., Ratner, D., Zhong, L., Esteves-Sena, M. & Gao, G. Production and discovery of novel recombinant adeno-associated viral vectors. Curr. Protoc. Microbiol. 14, 14D.1 (2012).","journal-title":"Curr. Protoc. Microbiol."},{"key":"9330_CR54","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"9330_CR55","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nmeth.4324","volume":"14","author":"H Pimentel","year":"2017","unstructured":"Pimentel, H., Bray, N. L., Puente, S., Melsted, P. & Pachter, L. Differential analysis of RNA-seq incorporating quantification uncertainty. Nat. Methods 14, 687\u2013690 (2017).","journal-title":"Nat. Methods"},{"key":"9330_CR56","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"9330_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"9330_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"9330_CR59","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie, M. et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 50, D687\u2013D692 (2022).","journal-title":"Nucleic Acids Res."},{"key":"9330_CR60","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","volume":"485","author":"DC Montefiori","year":"2009","unstructured":"Montefiori, D. C. Measuring HIV neutralization in a luciferase reporter gene assay. Methods Mol. Biol. 485, 395\u2013405 (2009).","journal-title":"Methods Mol. Biol."},{"key":"9330_CR61","doi-asserted-by":"publisher","unstructured":"Mehta, I. & jishnu-lab. jishnu-lab\/HIV_bnAbs_delivery: v2 (Version v2). Zenodo https:\/\/doi.org\/10.5281\/zenodo.15660099 (2025).","DOI":"10.5281\/zenodo.15660099"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09330-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09330-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09330-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T18:02:01Z","timestamp":1763575321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09330-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":61,"journal-issue":{"issue":"8082","published-print":{"date-parts":[[2025,9,25]]}},"alternative-id":["9330"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09330-2","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the Acknowledgements did not include thanks for funding from the HIV\/AIDS and Emerging Infectious Diseases Institute at the University of Miami through the State of Florida Funding Initiative, as is now amended in the HTML and PDF versions of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A.M., M.R.G. and M.F. have significant financial interests in Emmune Inc., a company that is developing HIV immunotherapies based on the immunoadhesin eCD4-Ig. These potential conflicts of interest are being managed by the authors\u2019 respective institutions. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}